Colgate-Palmolive grants 7,477 options to EVP
Colgate-Palmolive’s EVP and Controller received new stock options and restricted stock units as part of the company’s incentive compensation plan.
Rhea-AI Filing Summary
COLGATE PALMOLIVE CO (symbol: CL) is the issuer of record for a Form 4 filing submitted to the SEC. Malcolm Gregory reported acquisition or exercise transactions in this Form 4 filing.
COLGATE PALMOLIVE CO (CL) reported that EVP and Controller Gregory Malcolm received equity awards on September 16, 2026. He was granted 7,477 stock options to buy common shares at $87.02 per share, expiring September 16, 2036, vesting in one-third increments starting one year after the grant date. He also received a restricted stock unit award of 1,081 common shares, vesting in equal one-third installments on each of the first, second and third anniversaries of the grant date. After these awards, he holds 14,162 common shares directly and 8,650 common shares indirectly through the issuer’s 401(k) plan trustee; no Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 8,558 shares
Grant/Award
3 txns
Insider
Malcolm Gregory
Role
EVP and Controller
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2, F3 | 7,477 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 1,081 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 7,477 contracts (Direct);
Common Stock — 14,162 shares (Direct);
Common Stock — 8,650 shares (Indirect, By Issuer's 401(k) Plan Trustee)
Footnotes (3)
- F1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.
- F2. Stock option award granted under the issuer's incentive compensation plan.
- F3. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.
Key Figures
Stock options granted: 7,477 options
Option exercise price: $87.02 per share
Option expiration date: September 16, 2036
+3 more
6 metrics
Stock options granted
7,477 options
Stock option award to EVP and Controller on September 16, 2026
Option exercise price
$87.02 per share
Exercise price for 7,477 stock options granted September 16, 2026
Option expiration date
September 16, 2036
Expiration of stock options granted to EVP and Controller
Restricted stock units granted
1,081 shares
RSU award granted September 16, 2026, vesting over three years
Direct common shares after transaction
14,162 shares
Direct holdings of Colgate-Palmolive common stock after grants
Indirect 401(k) holdings
8,650 shares
Common stock held indirectly by issuer’s 401(k) plan trustee
Key Terms
restricted stock unit, incentive compensation plan, stock option award, 401(k) Plan Trustee
4 terms
restricted stock unit financial
"Restricted stock unit award granted under the issuer's incentive compensation plan."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
incentive compensation plan financial
"award granted under the issuer's incentive compensation plan."
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
stock option award financial
"Stock option award granted under the issuer's incentive compensation plan."
A stock option award is a grant that gives an employee the right to buy a company’s shares at a fixed price for a limited time, often becoming available gradually over a set schedule. Investors care because these awards align workers’ incentives with company performance, can increase employee loyalty, and may create future share dilution and compensation expense that affect earnings per share and shareholder value.
401(k) Plan Trustee financial
"By Issuer's 401(k) Plan Trustee"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Colgate-Palmolive (CL) grant to EVP and Controller Gregory Malcolm?
He received 7,477 stock options with an exercise price of $87.02 per share and a restricted stock unit award of 1,081 common shares, all granted under Colgate-Palmolive’s incentive compensation plan on September 16, 2026.
How do the new stock options for CL’s EVP and Controller vest and expire?
The 7,477 stock options become exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date and expire on September 16, 2036, with an exercise price of $87.02 per share.
How do the restricted stock units granted by CL to its EVP and Controller vest?
The 1,081 restricted stock units vest in equal one-third installments on each of the first, second and third anniversaries of the September 16, 2026 grant date, under Colgate-Palmolive’s incentive compensation plan.
What are Gregory Malcolm’s direct common stock holdings in Colgate-Palmolive (CL) after these awards?
After the reported awards, Gregory Malcolm directly holds 14,162 shares of Colgate-Palmolives common stock, according to the Form 4 filing for the transactions dated September 16, 2026.
What indirect holdings in CL common stock are reported for the EVP and Controller?
The filing reports 8,650 shares of Colgate-Palmolive common stock held indirectly for Gregory Malcolm by the issuer’s 401(k) plan trustee, in addition to his directly held shares.
Were the CL insider transactions made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the equity awards were made under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
